Allergan's Mohawk evergreening patent deal draws criticism, but ultimately may flop
Nature Biotechnology 35, 1002 (2017).
doi:10.1038/nbt1117-1002
Author: Eva von Schaper
Source: Nature Biotechnology - Category: Biotechnology Authors: Eva von Schaper Tags: News Source Type: research
More News: Allergy | Biotechnology